Considering that dexamethasone is commonly used in patients with glioblastoma to control symptoms related to brain edema, the activation of the AR pathway via heterodimerization with GR may lead to an increase in the expression of ARGs and, consequently, an increase in the AR score. Here, NR3C1 is linked to glioblastoma.